🇺🇸 FDA
Patent

US 6194206

Use of oligonucleotide telomerase inhibitors to reduce telomere length

expired A61KA61K31/522A61K31/70

Quick answer

US patent 6194206 (Use of oligonucleotide telomerase inhibitors to reduce telomere length) held by THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS expires Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
THE UNIVERSTY OF TEXAS SYSTEM,BOARD OF REGENTS
Grant date
Tue Feb 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/522, A61K31/70, A61K31/7076, A61K31/711